Mindmed to participate in the 34th annual oppenheimer healthcare life sciences conference

New york--(business wire)---- $mnmd--mind medicine (mindmed) inc. (nasdaq: mnmd) (cboe canada: mmed) (the “company” or “mindmed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the company's management team will participate in the 34th annual oppenheimer healthcare life sciences conference: 34th annual oppenheimer healthcare life sciences conference format: presentation date and time: tuesday, february 13, 2.
MNMD Ratings Summary
MNMD Quant Ranking